S22-232 Methodology for tailoring target-specific ultrasound contrast agent production with pre-formed ligand-phospholipid bioconjugates Stanford researchers have developed a new controllable methodology for molecularly targeted ultrasound contrast agent production with pre-formed ligand-phospholipid bioconjugates. Rakesh Bam Jeremy Dahl